Trauma to a tissue with impairment and reestablishment of the blood supply, ischemiareperfusion,or after a burn, can lead to an injury that is augmented by the body's own immune system. Mastcells (MC) play an important role in progression of such an autologous inflammatory response in skeletalmuscle and small intestine and after a cutaneous burn, possibly contributing to irreversible injury withscarring. Through the use of mice lacking specific secretory granule neutral proteases, mouse MC protease5 (mMCP-5) has been found to participate in each of these models of immune injury. In addition, mMCP-4which has a substrate specificity different from mMCP-5 has been found to also participlate in burn injury.This genetic evidence will be extended by more detailed characterization of the MC response and tissuepathobiology and confirmed by pharmacologic approaches using active site inhibitors and recombinantmMCP-5. The mechanism for MC activation, presumed to be via generation of complement fragments, C3a6 C5a, will be established by showing protection against autologous immune injury in a strain deficient inone receptor and pharmacologically blocked at the other or by using a strain deficient in both receptors. Thepossibility that irreversible injury requires the action of the terminal cytotoxic complex of five complementproteins and a MC protease will be addressed by showing protection in a new strain generated so as to bedeficient in MC and in formation of the complement complex but intact for the activating portion of thecomplement pathway. In each of these three aims the final proof for involvement of a particularprotein will be by reconstituting injury in a deficient strain with adoptive transfer of wild type MC but notdeficient MC.

Public Health Relevance

. Understanding the mechanism of MC activation in autologous immuneinflammation, the specificity of the mMCPs involved, and the interplay of the mMCPs with the cytotoxiccomplement complex in irreversible injury with scarring should provide therapeutic targets.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
2P50GM052585-14
Application #
7428732
Study Section
Special Emphasis Panel (ZGM1-PPBC-6 (TB))
Project Start
2008-09-16
Project End
2011-08-31
Budget Start
2008-09-16
Budget End
2009-08-31
Support Year
14
Fiscal Year
2008
Total Cost
$458,882
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Sadeghipour, Hamed; Torabi, Radbeh; Gottschall, James et al. (2017) Blockade of IgM-Mediated Inflammation Alters Wound Progression in a Swine Model of Partial-Thickness Burn. J Burn Care Res 38:148-160
Sheu, Eric G; Wakatsuki, Kohei; Oakes, Sean et al. (2016) Prevention of intestinal ischemia-reperfusion injury in humanized mice. Surgery 160:436-42
Bankova, L G; Dwyer, D F; Liu, A Y et al. (2015) Maturation of mast cell progenitors to mucosal mast cells during allergic pulmonary inflammation in mice. Mucosal Immunol 8:596-606
Dwyer, Daniel F; Woodruff, Matthew C; Carroll, Michael C et al. (2014) B cells regulate CD4+ T cell responses to papain following B cell receptor-independent papain uptake. J Immunol 193:529-39
Bankova, Lora G; Lezcano, Cecilia; Pejler, Gunnar et al. (2014) Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol 192:2812-20
Houde, Martin; Jamain, Marc-David; Labonte, Julie et al. (2013) Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1. J Pharmacol Exp Ther 346:31-7
Gurish, Michael F; Austen, K Frank (2012) Developmental origin and functional specialization of mast cell subsets. Immunity 37:25-33
Younan, George J; Heit, Yvonne I; Dastouri, Pouya et al. (2011) Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast Reconstr Surg 128:649e-58e
Afnan, Jalil; Ahmadi-Yazdi, Cyrus; Sheu, Eric G et al. (2010) Inhibition of rat gut reperfusion injury with an agent developed for the mouse. Evidence that amplification of injury by innate immunity is conserved between two animal species. Am J Physiol Regul Integr Comp Physiol 298:R1675-81
Haas, Michael S; Alicot, Elisabeth M; Schuerpf, Franziska et al. (2010) Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc Res 87:618-27

Showing the most recent 10 out of 34 publications